PL1670448T3 - Sulfonamidy inhibitujące HCV - Google Patents

Sulfonamidy inhibitujące HCV

Info

Publication number
PL1670448T3
PL1670448T3 PL04766871T PL04766871T PL1670448T3 PL 1670448 T3 PL1670448 T3 PL 1670448T3 PL 04766871 T PL04766871 T PL 04766871T PL 04766871 T PL04766871 T PL 04766871T PL 1670448 T3 PL1670448 T3 PL 1670448T3
Authority
PL
Poland
Prior art keywords
sulfonamides
hcv inhibiting
hcv
inhibiting
inhibiting sulfonamides
Prior art date
Application number
PL04766871T
Other languages
English (en)
Inventor
Kenneth Alan Simmen
Acker Koenraad Lodewijk August Van
Piet Tom Bert Paul Wigerinck
Dominique Louis Nestor Ghislain Surleraux
Géry Karel Julia Dams
Ludo Maria Marcel Quirynen
Kurt Hertogs
Rudi Wilfried Jan Pauwels
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of PL1670448T3 publication Critical patent/PL1670448T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL04766871T 2003-09-30 2004-09-30 Sulfonamidy inhibitujące HCV PL1670448T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03103629 2003-09-30
US50753503P 2003-10-01 2003-10-01
PCT/EP2004/052388 WO2005030194A1 (en) 2003-09-30 2004-09-30 Hcv inhibitiing sulfonamides
EP04766871A EP1670448B1 (en) 2003-09-30 2004-09-30 Hcv inhibiting sulfonamides

Publications (1)

Publication Number Publication Date
PL1670448T3 true PL1670448T3 (pl) 2008-04-30

Family

ID=34924108

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04766871T PL1670448T3 (pl) 2003-09-30 2004-09-30 Sulfonamidy inhibitujące HCV

Country Status (8)

Country Link
US (1) US20080234288A1 (pl)
EP (1) EP1670448B1 (pl)
JP (1) JP2007507469A (pl)
DE (1) DE602004010291T2 (pl)
ES (1) ES2297467T3 (pl)
PL (1) PL1670448T3 (pl)
PT (1) PT1670448E (pl)
WO (1) WO2005030194A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2607617A1 (en) 2005-05-09 2006-11-16 Achillion Pharmaceuticals, Inc. Thiazole compounds and methods of use
JO2841B1 (en) * 2006-06-23 2014-09-15 تيبوتيك فارماسيوتيكالز ليمتد 2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
US20120220520A1 (en) * 2006-10-17 2012-08-30 Van T Klooster Gerben Albert Eleutherius Bioavailable combinations for hcv treatment
EA026673B1 (ru) * 2008-10-07 2017-05-31 Янссен Сайенсиз Айрлэнд Юси Амидные соединения в качестве усилителей противовирусных препаратов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174587T1 (de) * 1993-08-24 1999-01-15 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
GB9815567D0 (en) * 1998-07-18 1998-09-16 Glaxo Group Ltd Antiviral compound
MY164523A (en) * 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
JP4578101B2 (ja) * 2001-12-21 2010-11-10 テイボテク・フアーマシユーチカルズ・リミテツド 幅広いスペクトルのｈｉｖプロテアーゼ阻害剤である複素環置換フェニル含有スルホンアミド
CA2369970A1 (en) * 2002-02-01 2003-08-01 Boehringer Ingelheim (Canada) Ltd. Hepatitis c inhibitor tri-peptides

Also Published As

Publication number Publication date
DE602004010291T2 (de) 2008-10-09
EP1670448A1 (en) 2006-06-21
DE602004010291D1 (de) 2008-01-03
EP1670448B1 (en) 2007-11-21
PT1670448E (pt) 2008-02-11
JP2007507469A (ja) 2007-03-29
WO2005030194A1 (en) 2005-04-07
US20080234288A1 (en) 2008-09-25
ES2297467T3 (es) 2008-05-01

Similar Documents

Publication Publication Date Title
GB2401643B (en) Padlock
TWI372050B (en) (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
GB2381557B (en) Padlock
AU155161S (en) Case
GB2421120B (en) Switch
GB2400735B (en) Switch
GB0402095D0 (en) Circuit
GB0407174D0 (en) Switch
GB0224861D0 (en) Signalling
PL1670448T3 (pl) Sulfonamidy inhibitujące HCV
IL172131A0 (en) Nematicidal thiazoline-containing fluorobutenes
GB0318411D0 (en) Vessel
GB0307643D0 (en) Markers
AU2003291303A8 (en) Sulfonamides
GB0407188D0 (en) Switch
AU2003291262A8 (en) Sulfonamides
AU2003295408A8 (en) Sulfonamides
AU156699S (en) Necktie
GB2405572B (en) Bib
GB0325680D0 (en) Switch arrangement
GB0307640D0 (en) Markers
AU156700S (en) Necktie
GB0301412D0 (en) Mult-hull watercraft
GB0328974D0 (en) Bib
GB0301960D0 (en) Improved glove